Skip to main content
OpenTrials

Clinical trial condition

Neurocognitive Disorders

Explore clinical trials studying Neurocognitive Disorders. Study availability and eligibility vary by location and protocol.

83 public trials 25 recruiting studies
Refine in advanced search Browse all conditions

Neurocognitive Disorders trial results

Active, not recruiting

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

NCT05508789

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +11 more
Locations
  • Hospital Italiano de Buenos Aires ABB, Argentina
  • Clinica Privada Banfield Banfield, Argentina
  • Fundación para el Estudio y Tratamiento de Enfermedades Mentales (FETEM) Buenos Aires, Argentina
  • Stat Research S.A. Buenos Aires, Argentina
View all 141 locations
View Trial Details
Active, not recruiting

A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)

NCT05738486

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations
  • MD First Research - Chandler Chandler, Arizona, United States
  • Irvine Clinical Research Irvine, California, United States
  • Healthy Brain Clinic Long Beach, California, United States
  • California Neuroscience Research Medical Group, Inc. Sherman Oaks, California, United States
View all 49 locations
View Trial Details
Completed

A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation

NCT05318976

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +12 more
Locations
  • INmune Bio Investigational Site Darlinghurst, New South Wales, Australia
  • INmune Bio Investigational Site Macquarie Park, New South Wales, Australia
  • INmune Bio Investigational Site Adelaide, South Australia, Australia
  • INmune Bio Investigational Site Box Hill, Victoria, Australia
View all 41 locations
View Trial Details

Related conditions